Cargando…
Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy
[Image: see text] Human African Trypanosomiasis (HAT), caused by Trypanosoma brucei, is one of the neglected tropical diseases with a continuing need for new medication. We here describe the discovery of 5-phenylpyrazolopyrimidinone analogs as a novel series of phenotypic antitrypanosomal agents. Th...
Autores principales: | Zheng, Yang, van den Kerkhof, Magali, van der Meer, Tiffany, Gul, Sheraz, Kuzikov, Maria, Ellinger, Bernhard, de Esch, Iwan J. P., Siderius, Marco, Matheeussen, An, Maes, Louis, Sterk, Geert Jan, Caljon, Guy, Leurs, Rob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424178/ https://www.ncbi.nlm.nih.gov/pubmed/37471520 http://dx.doi.org/10.1021/acs.jmedchem.3c00161 |
Ejemplares similares
-
Structural Optimization of BIPPO Analogs as Potent Antimalarials
por: Zheng, Yang, et al.
Publicado: (2023) -
Discovery of Diaryl Ether Substituted Tetrahydrophthalazinones as TbrPDEB1 Inhibitors Following Structure-Based Virtual Screening
por: de Heuvel, Erik, et al.
Publicado: (2021) -
Structure‐Activity Relationship of Phenylpyrazolones against Trypanosoma cruzi
por: Sijm, Maarten, et al.
Publicado: (2020) -
Structure Activity Relationship of N-Substituted Phenyldihydropyrazolones Against Trypanosoma cruzi Amastigotes
por: Sijm, Maarten, et al.
Publicado: (2021) -
The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines
por: Robinson, William J., et al.
Publicado: (2021)